ARISTOCORT R OINTMENT

Ülke: Kanada

Dil: İngilizce

Kaynak: Health Canada

Aktif bileşen:

TRIAMCINOLONE ACETONIDE

Mevcut itibaren:

BAUSCH HEALTH, CANADA INC.

ATC kodu:

D07AB09

INN (International Adı):

TRIAMCINOLONE

Doz:

0.1%

Farmasötik formu:

OINTMENT

Kompozisyon:

TRIAMCINOLONE ACETONIDE 0.1%

Uygulama yolu:

TOPICAL

Paketteki üniteler:

30G

Reçete türü:

Prescription

Terapötik alanı:

ANTI-INFLAMMATORY AGENTS

Ürün özeti:

Active ingredient group (AIG) number: 0106310002; AHFS:

Yetkilendirme durumu:

APPROVED

Yetkilendirme tarihi:

2014-10-15

Ürün özellikleri

PRESCRIBING INFORMATION - PLEASE RETAIN FOR FUTURE REFERENCE
PR ARISTOCORT
®

Triamcinolone acetonide
ARISTOCORT R CREAM 0.1%
ARISTOCORT C CREAM 0.5%
ARISTOCORT R OINTMENT 0.1%
TOPICAL CORTICOSTEROID CREAMS AND OINTMENTS
ACTION: Topical steroid products are effective because of their
anti-inflammatory, antipruritic and vasoconstrictive properties.
INDICATIONS: Indicated for topical therapy of corticosteroid
responsive acute and chronic dermatoses, where an anti-inflammatory,
anti-
allergenic and antipruritic activity in topical management is
required.
ARISTOCORT triamcinolone acetonide topical preparations have been
demonstrated to be effective in the adjunctive treatment of the
following dermatoses: atopic dermatitis, pruritus vulvae and ani,
generalized erythorodermia, external otitis, seborrheic dermatitis,
eczematized
psoriasis, neurodermatitis.
The concentrated 0.5 % ARISTOCORT C triamcinolone acetonide
preparation has been of greatest usefulness in the initial suppression
of the
acute manifestations of difficult to manage dermatologic conditions.
The regular 0.1% ARISTOCORT R topical preparations are indicated
for the control of dermatoses, once difficult conditions are
suppressed.
ARISTOCORT Ointment is preferable to creams when one is dealing with a
dry lesion, whereas the cream base formulations are preferable on
weeping lesions.
It must be remembered that steroid therapy, although responsible for
remissions of dermatoses, especially of allergic origin, cannot be
expected to prevent recurrence. In the case of contact or allergic
dermatitis, it is important to investigate causal factors and to
remove the
offending material or allergen.
CONTRAINDICATIONS: Topical steroids are contraindicated in:
1. Untreated bacterial, tubercular and fungal infections involving the
skin, and in certain viral diseases such as herpes simplex, chicken
pox, and
vaccinia.
2. Hypersensitivity to any of the components.
WARNINGS: The safety of topical corticosteroids during pregnancy and
lactation has not been established. The